Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions

• DOI: 10.1007/s12471-015-0652-2
• Publication Date: 2015-01-27T12:38:09Z
• Authors: Cordula Felix; Bert Everaert; Roberto Diletti; Nicolas Van Mieghem; Joost Daemen; Marco Valgimigli; Peter P. de Jaegere; Felix Zijlstra; Evelyn Regar; Cihan Simsek; Yoshinobu Onuma; Robert-Jan M. van...
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Review Article; Cardiology and Cardiovascular Medicine; EMC COEUR-09; 3. Good health

Drug-eluting stents (DES) are widely used as first choice devices in percutaneous coronary interventions. However, certain concerns associated with the use of DES, i.e. delayed arterial healing a subsequent risk neo-atherosclerosis, late stent thrombosis and hypersensitivity reactions to DES polymer. Bioresorbable vascular scaffolds next step interventions introducing concept supporting natural process following initial intervention without leaving any foreign body materials resulting adverse events. The first-generation have shown encouraging results multiple studies selected patients up point full bioresorption, introduction regular patient care. During its daily clinical practice outside previously groups, careful approach should be followed which outcome is continuously monitored.